Register / Log In

Tips to addressing cataract surgery challenges in glaucomatous eyes

Use of various temporary and permanent devices for successful outcomes highlighted


Patients needing glaucoma surgery may also be candidates for a combined procedure with cataract removal and IOL implantation. For a variety of reasons, however, cataract surgery may be challenging in eyes with glaucoma.

Alan S. Crandall, MD, provided a sampling of cases to demonstrate the complexities encountered when performing cataract surgery in glaucoma patients and strategies for achieving successful outcomes.

Further reading: Innovation in glaucoma thriving 

“Considering the number of combination cases we perform, I have always felt that glaucoma surgeons should also be the best cataract surgeons,” said Dr. Crandall, professor and senior vice chairman of ophthalmology and visual sciences, and director of glaucoma and cataract at the John A. Moran Eye Center, University of Utah, Salt Lake City.

Videos from cases with pseudoexfoliation and traumatic glaucoma highlighted the potential for encountering eyes with weak, loose, and missing zonules. In eyes with traumatic glaucoma, Dr. Crandall cautioned that the extent of the zonular dialysis is probably much greater than what is initially perceived.

“In eyes with trauma, the area of zonular dialysis is probably doubled or tripled,” Dr. Crandall said. “If you see 100 degrees of dialysis, you can expect at least 2 clock hours of additional involvement on the other side.”

 

NEXT: Tips for enhancing safety + Video

The advent of 24-hour IOP monitoring will transform the care of patients with glaucoma and usher in a new era of personalizing IOP. 24-hour IOP monitoring set to revolutionize glaucoma research and clinical care.

The next decade will be a period of remarkable research discoveries for glaucoma and their translation into enhanced patient care, according to Robert N. Weinreb, MD. Glaucoma research will transform and will dramatically change the clinical practice. Dr. Weinreb discussed improvements in risk-prediction and risk-modification strategies, increased knowledge of glaucoma pathophysiology, the advent of 24-hour IOP monitoring, and advanced technologies for structural and functional imaging.

Listen as Gil Kliman, MD, managing director of InterWest Partners, interviews Richard Lindstrom, MD, in a one-on-interview at the 2014 Glaucoma 360 meeting. Dr. Lindstrom recalls how he was primed as a boy for the construction business by his father, but decided to go to medical school. The decision catapulted Dr. Lindstrom’s career as ophthalmologist, surgeon, and product innovator.

The search for glaucoma biomarkers is in high gear. Funded by Catalyst for a Cure, the research program has already produced new biomarker candidates and novel techniques that promise to advance research in glaucoma. Research is focusing on ways to diagnose glaucoma early and detect the specific, minute changes that could allow researchers to reduce vision loss.

Intraocular pressure (IOP) monitoring is based on fiction. Clinicians typically measure IOP over a single visit and extrapolate the value to the patient’s overall condition and the degree of control over their IOP. “New Horizons in IOP Monitoring and Digital Health” session showcased six companies trying to turn the IOP challenge into commercial success.